Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Four-part, Phase 1, Double-blind Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) with Single and Multiple Ascending Oral Doses of OD-07656 in Healthy, Adult Male and Female Participants

NCT06206811 is registered in ClinicalTrials.gov with Odyssey Therapeutics as lead sponsor.

NCT NCT06206811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06206811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Four-part, Phase 1, Double-blind Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) with Single and Multiple Ascending Oral Doses of OD-07656 in Healthy, Adult Male and Female Participants
Lead sponsor
Odyssey Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
February 12, 2024
Completion date
November 25, 2024
Enrollment
101 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blau syndrome, crohn disease, inflammatory bowel diseases, spondyloarthritis, ulcerative colitis